A novel rating scale for the measurement of apathy in institutionalized persons with dementia: The APADEM-NH

American Journal of Geriatric Psychiatry

Volumn 23, Issue 2, 2015, Pages 149-159

  Agüera Ortiz, Luis ^a,b   Gil Ruiz, Nuria ^a   Cruz Orduña, Isabel ^a   Ramos García, Isabel ^a   Osorio, Ricardo S ^c   Valentí Soler, Meritxell ^a   Olazarán Rodriguez, Javier ^a   Dobato Ayuso, José L ^a   Lanctôt, Krista ^d   Martínez Martín, Pablo ^a,e  

^a Instituto de Salud Carlos III   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^e CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

Author keywords

Apathy; dementia; institutionalized persons; psychometrics; rating scale; validation study

Indexed keywords

AGED; ALZHEIMER DISEASE; APATHY IN DEMENTIA NURSING HOME SCALE; ARTICLE; CEREBROVASCULAR DISEASE; DIFFUSE LEWY BODY DISEASE; DISEASE SEVERITY ASSESSMENT; FEMALE; HUMAN; INTERNAL CONSISTENCY; INTERNAL VALIDITY; INTERRATER RELIABILITY; ITEM TOTAL CORRELATION; MAJOR CLINICAL STUDY; MALE; PSYCHOLOGICAL RATING SCALE; TEST RETEST RELIABILITY; APATHY; DEMENTIA; INSTITUTIONALIZATION; PSYCHOLOGY; PSYCHOMETRY; VALIDATION STUDY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; APATHY; DEMENTIA; FEMALE; HUMANS; INSTITUTIONALIZATION; MALE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS;

EID: 84928034677     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1016/j.jagp.2013.01.079     Document Type: Article

References (47)

1. Levy R, Dubois B: Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits. Cereb Cortex 2006; 16: 916-928
2. Robert P, Onyike CU, Leentjens AF, et al: Proposed diagnostic criteria for apathy in Alzheimer's disease and other neuropsychiatric disorders. Eur Psychiatry 2009; 24:98-104
3. Landes AM, Sperry SD, Strauss ME: Apathy in Alzheimer's disease. J Am Geriatr Soc 2001; 49:1700-1707
4. Zuidema S, Koopmans R, Verhey F: Prevalence and predictors of neuropsychiatric symptoms in cognitively impaired nursing home patients. J Geriatr Psychiatry Neurol 2007; 20:41-49
5. Garcia-Alberca JM, Pablo Lara J, Gonzalez-Baron S, et al: [Prevalence and comorbidity of neuropsychiatric symptoms in Alzheimer's disease]. Actas Esp Psiquiatr 2008; 36:265-270
6. Onyike CU, Sheppard JM, Tschanz JT, et al: Epidemiology of apathy in older adults: the Cache County Study. Am J Geriatr Psychiatry 2007; 15:365-375
7. Cummings JL, Mega M, Gray K, et al: The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994; 44:2308-2314
8. Wetzels RB, Zuidema SU, de Jonghe JF, et al: Course of neuropsychiatric symptoms in residents with dementia in nursing homes over a 2-year period. Am J Geriatr Psychiatry 2010; 18:1054-1065
9. Tun SM, Murman DL, Long HL, et al: Predictive validity of neuropsychiatric subgroups on nursing home placement and survival in patients with Alzheimer disease. Am J Geriatr Psychiatry 2007; 15:314-327
10. Berman K, Brodaty H, Withall A, et al: Pharmacologic treatment of apathy in dementia. Am J Geriatr Psychiatry 2012; 20:104-122
11. Brodaty H, Burns K: Nonpharmacological management of apathy in dementia: a systematic review. Am J Geriatr Psychiatry 2012; 20:549-564
12. Marin RS: Differential diagnosis and classification of apathy. Am J Psychiatry 1990; 147:22-30
13. Starkstein SE, Ingram L, Garau ML, et al: On the overlap between apathy and depression in dementia. J Neurol Neurosurg Psychiatry 2005; 76:1070-1074
14. Marin RS, Biedrzycki RC, Firinciogullari S: Reliability and validity of the Apathy Evaluation Scale. Psychiatry Res 1991; 38:143-162
15. Lueken U, Seidl U, Volker L, et al: Development of a short version of the Apathy Evaluation Scale specifically adapted for demented nursing home residents.AmJ Geriatr Psychiatry 2007; 15:376-385
16. Starkstein SE, Mayberg HS, Preziosi TJ, et al: Reliability, validity, and clinical correlates of apathy in Parkinson's disease. J Neuropsychiatry Clin Neurosci 1992; 4:134-139
17. Robert PH, Clairet S, Benoit M, et al: The apathy inventory: assessment of apathy and awareness in Alzheimer's disease, Parkinson's disease and mild cognitive impairment. Int J Geriatr Psychiatry 2002; 17:1099-1105
18. Strauss ME, Sperry SD: An informant-based assessment of apathy in Alzheimer disease. Neuropsychiatry Neuropsychol Behav Neurol 2002; 15:176-183
19. Sockeel P, Dujardin K, Devos D, et al: The Lille apathy rating scale (LARS), a new instrument for detecting and quantifying apathy: validation in Parkinson's disease. J Neurol Neurosurg Psychiatry 2006; 77:579-584
20. American Psychiatric Association: DSM-IV-TR: Breviario: Criterios diagnósticos. Barcelona, Masson, 2003
21. Agüera-Ortiz L, Gil-Ruiz N, Cruz-Orduña I, et al: Creación de una escala de medición de la apatía en pacientes con demencia tipo Alzheimer institucionalizados: la escala APADEM-NH-66. Psicogeriatría 2010; 4:207-219
22. Agüera-Ortiz L, Cruz-Orduña I, Ramos-García M, et al: Proceso de creación de la escala APADEM-NH para la medición de la apatía en pacientes con demencia institucionalizados. Psicogeriatría 2011; 3:29-36
23. Reisberg B, Ferris SH, de Leon MJ, et al: The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 1982; 139:1136-1139
24. Morris JC: The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993; 43:2412-2414
25. Boada M, Tarraga L, Modinos G, et al: [Neuropsychiatric Inventory-Nursing Home version (NPI-NH): Spanish validation]. Neurologia 2005; 20:665-673
26. Alexopoulus G, Abrams R, Young R, et al: Cornell scale for depression in dementia. Biol Psychiatry 1988:271-284
27. Pujol J, De Azpiazu P, Salamero M, et al: [Depressive symptoms in dementia. The Cornell scale: validation of the Spanish version]. Rev Neurol 2001; 33:397-398
28. Marinus J, Visser M, van Hilten JJ, et al: Assessment of sleep and sleepiness in Parkinson disease. Sleep 2003; 26:1049-1054
29. van der Linden FA, Kragt JJ, Klein M, et al: Psychometric evaluation of the multiple sclerosis impact scale (MSIS-29) for proxy use. J Neurol Neurosurg Psychiatry 2005; 76:1677-1681
30. Martinez-Martin P, Rodriguez-Blazquez C, Abe K, et al: International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease. Neurology 2009; 73:1584-1591
31. McHorney CA, Tarlov AR: Individual-patient monitoring in clinical practice: are available health status surveys adequate Qual Life Res 1995; 4:293-307
32. Hays RD, Anderson R, Revicki D: Psychometric considerations in evaluating health-related quality of life measures. Qual Life Res 1993; 2:441-449
33. Scientific Advisory Committee of the Medical Outcomes Trust: Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res 2002; 11:193-205
34. Ware JE Jr., Gandek B: Methods for testing data quality, scaling assumptions, and reliability: the IQOLA Project approach. International Quality of Life Assessment. J Clin Epidemiol 1998; 51:945-952
35. Eisen M, Ware JE Jr., Donald CA, et al: Measuring components of children's health status. Med Care 1979; 17:902-921
36. Chassany O, Sagnier P, Marquis P, et al: Patient-reported outcomes: the example of health-related quality of life a European guidance document for the improved integrationofhealth-related qualityof life assessment in the drug regulatory process. Drug Inf J 2002:209-238
37. Terwee CB, Bot SD, de Boer MR, et al: Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 2007; 60:34-42
38. Juniper EF, Guyatt GH, Jaeschke R: How to develop and validate a new quality of life instrument. In: Spilker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials, 2nd ed. Philadelphia, PA: Lippincott-Raven Publishers, 1996:49-56
39. Hobart J, Lamping D, Fitzpatrick R, et al: The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure. Brain 2001; 124:962-973
40. Yeager CA, Hyer L: Apathy in dementia: relations with depression, functional competence, and quality of life. Psychol Rep 2008; 102:718-722
41. Clarke DE, Ko JY, Kuhl EA, et al: Are the available apathy measures reliable and valid A review of the psychometric evidence. J Psychosom Res 2011; 70:73-97
42. Levy ML, Cummings JL, Fairbanks LA, et al: Apathy is not depression. J Neuropsychiatry Clin Neurosci 1998; 10:314-319
43. Lyketsos CG, Lopez O, Jones B, et al: Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA 2002; 288: 1475-1483
44. Norman GR, Sloan JA, Wyrwich KW: Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003; 41:582-592
45. Mulin E, Leone E, Dujardin K, et al: Diagnostic criteria for apathy in clinical practice. Int J Geriatr Psychiatry 2011; 26:158-165
46. Agüera-Ortiz L, Cruz-Orduna I, Ramos García I, et al: Apathy dimensions evolve diffferently with levels of dementia severity. Alzheimers Dement 2012; 8:622
47. Leone E, Deudon A, Bauchet M, et al: Management of apathy in nursing homes using a teaching program for care staff: the STIM-EHPAD study. Int J Geriatr Psychiatry 2013; 28: 383-392